Edwards receives FDA approval for mitral valve replacement system
Edwards Lifesciences has received the US Food and Drug Administration (FDA) approval for its SAPIEN M3 mitral valve replacement system.…
News
Shape Memory Medical’s embolisation plugs gain CE mark under EU MDR
Fulgent Genetics to buy Bako Diagnostics assets and StrataDx
FDA approves Abbott’s Volt PFA system for atrial fibrillation
Neurable secures $35m to expedite BCI technology commercialisation
ZOLL introduces next-gen wearable cardioverter defibrillator in US
CellBxHealth’s new CEO pivots strategy amid financial turnaround efforts
Curasight doses first patient in Phase I brain cancer trial of uTREAT
